ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 596,07
0,29%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Organovo Holdings Inc (ONVO)

  7. Organovo Holdings Inc (ONVO) Actualités

ONVO Organovo Holdings Inc

1,00
0,0119 (1,20%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Organovo Holdings Inc ONVO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0119 1,20% 1,00 23:58:32
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,9881 0,9801 1,0256 1,00 0,9881
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
15/4/202414:05GLOBEOrganovo Announces Positive Phase 2 Results for FXR314 in..
09/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
08/2/202422:56EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202414:05EDGAR2Form 8-K - Current report
26/1/202423:09EDGAR2Form S-3 - Registration statement under Securities Act of..
25/1/202414:05GLOBEOrganovo Presents FXR314 3D Human Tissue Model Findings That..
09/1/202414:05GLOBEOrganovo To Present FXR314 IBD 3D Model Findings at Upcoming..
28/12/202322:05EDGAR2Form 8-K - Current report
22/12/202312:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202314:05GLOBEOrganovo Provides Timing for Release of FXR314 Phase 2 NASH..
01/12/202322:07EDGAR2Form S-8 - Securities to be offered to employees in employee..
18/11/202300:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202300:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202300:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202300:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202300:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202322:41EDGAR2Form 144 - Report of proposed sale of securities
13/11/202314:05GLOBECORRECTION – Organovo Highlights FXR314 Combination Therapy..
09/11/202323:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202314:05GLOBEOrganovo Highlights FXR314 Combination Therapy Potential and..
03/11/202313:05EDGAR2Form 8-K - Current report
22/9/202322:05EDGAR2Form 8-K/A - Current report: [Amend]
13/9/202323:06EDGAR2Form DEF 14A - Other definitive proxy statements
13/9/202323:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/9/202322:11EDGAR2Form 8-K - Current report
08/9/202318:46GLOBEOrganovo to Participate in the H.C. Wainwright Global..
05/9/202312:04EDGAR2Form 8-K - Current report
23/8/202314:05GLOBEOrganovo Advances Clinical Timelines for FXR314 and Provides..
22/8/202322:45EDGAR2Form 8-K - Current report
10/8/202322:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202322:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
24/7/202322:27EDGAR2Form 8-K - Current report
14/7/202323:05EDGAR2Form PRE 14A - Other preliminary proxy statements
29/6/202322:06EDGAR2Form NT 10-K - Notification of inability to timely file Form..

Dernières Valeurs Consultées

NASDAQ
ONVO
Organovo
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés